TNL Mediagene Gets Nasdaq Listing Extension
Ticker: TNMWF · Form: 6-K · Filed: Dec 29, 2025 · CIK: 2013186
| Field | Detail |
|---|---|
| Company | Tnl Mediagene (TNMWF) |
| Form Type | 6-K |
| Filed Date | Dec 29, 2025 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $1 B |
| Sentiment | neutral |
Sentiment: neutral
Topics: listing, compliance, nasdaq
TL;DR
Nasdaq grants TNL Mediagene listing extension, but they gotta meet conditions by Jan.
AI Summary
TNL Mediagene received notification on December 23, 2025, from the Nasdaq Hearings Panel that its request for continued listing on The Nasdaq Capital Market has been granted. The company must meet certain conditions by January 2026 to maintain its listing.
Why It Matters
This news is crucial for TNL Mediagene as it allows the company to continue trading on a major stock exchange, providing liquidity and access to capital markets for its investors and operations.
Risk Assessment
Risk Level: medium — While the listing has been granted, the conditionality implies ongoing risks related to meeting Nasdaq's requirements.
Key Players & Entities
- TNL Mediagene (company) — The company filing the report and seeking continued listing.
- Nasdaq Hearings Panel (company) — The body that granted the company's request for continued listing.
- The Nasdaq Stock Market LLC (company) — The exchange on which the company is listed.
- December 23, 2025 (date) — The date TNL Mediagene was notified by the Nasdaq Hearings Panel.
- January 2026 (date) — The deadline by which TNL Mediagene must meet certain conditions.
FAQ
What specific conditions must TNL Mediagene meet by January 2026 to maintain its Nasdaq listing?
The filing states that the continued listing is granted 'subject to the following:', but the specific conditions are not detailed in the provided text excerpt.
What was the reason for TNL Mediagene's request for continued listing on Nasdaq?
The filing does not explicitly state the reason for the request, but Nasdaq listing extensions are typically granted when a company is not meeting certain listing requirements.
When was TNL Mediagene notified about the Nasdaq Hearings Panel's decision?
TNL Mediagene was notified on December 23, 2025.
Which Nasdaq market is TNL Mediagene seeking to remain listed on?
TNL Mediagene is seeking continued listing on The Nasdaq Capital Market.
What is the filing type and period of report for this document?
This is a Form 6-K, a Report of Foreign Private Issuer, for the month of December 2025, with the period of report conformed to December 24, 2025.
Filing Stats: 576 words · 2 min read · ~2 pages · Grade level 14 · Accepted 2025-12-29 06:03:47
Key Financial Figures
- $1 B — the Listing Rule 5550(a)(2) (the “$1 Bid Price Rule”). It is a requireme
Filing Documents
- ea0270901-6k_tnlmedia.htm (6-K) — 15KB
- ea027090101ex99-1_tnlmedia.htm (EX-99.1) — 11KB
- 0001213900-25-125570.txt ( ) — 27KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. TNL Mediagene. Date: December 24, 2025 By: /s/ Tzu-Wei Chung Name: Tzu-Wei Chung Title: Chief Executive Officer 2